Main Article Content
Ian S. Zagon, PhD is Distinguished University Professor and Distinguished Educator at The Pennsylvania State University College of Medicine. He has had 4 decades of funded research resulting in more than 350 peer-reviewed publications, multiple patents and start-up companies. A significant discovery was identifying the mechanism of low dose naltrexone (LDN), and its role in diseases including diabetes, cancer, and multiple sclerosis. He has received numerous awards including the Cheston Berlin Service Award, Society of Experimental Biology and Medicine Distinguished Scientist Award, 27 consecutive annual Distinguished Teaching Awards, and the 2015 Innovator of the Year Award from Penn State University.
Patricia J. McLaughlin, MS, DEd is tenured Professor at the Pennsylvania State University College of Medicine and Director of the Anatomy Graduate Program. She has collaborated with Dr. Zagon on basic and translational research, and has published extensively on the role of the OGF-OGFr axis in the etiology, pathogenesis, and treatment of a wide variety of diseases. Dr. McLaughlin has received the College of Medicine Dean’s Lecturer Award, as well as the SEBM Distinguished Scientist Award. She has more than 15 patents on her work related to the OGF-OGFr axis, and is a co-founder, with Dr. Zagon, of ZoeGenics LLC.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of individual chapters belongs to the respective authors. The authors grant unrestricted publishing and distribution rights to the publisher. The electronic versions of the chapters are published under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Users are allowed to share and adapt the chapters for any non-commercial purposes as long as the authors and the publisher are explicitly identified and properly acknowledged as the original source. The books in their entirety are subject to copyright by the publisher. The reproduction, modification, republication and display of the books in their entirety, in any form, by anyone, for commercial purposes are strictly prohibited without the written consent of the publisher.